`

Tagged: drug repurposing

BBCR Specializes in Orphan and Personalized Medicine helping orphan drug developers find direction in clinical trials involving biologics, biosimilars, small molecules, medical devices, and repurposing.

December 21st, 2020 | drug repurposing

We help to Identify areas of need or economic interest that can help companies find homes for treatments for rare diseases and precision medicine. Developing drugs for rare diseases and precision medicine indications can be rewarding, but navigating the challenges is not for the faint of heart. Expert guidance is essential in an area where […]

Drug repurposing acts to lower the need for early stage clinical trials and can help identify new uses for existing drugs.

June 11th, 2020 | drug repurposing

People tend to believe that a repurposed therapy can never be truly novel or transformative. Nothing could be further from the truth. One attractive option of Drug Repurposing is to use a scientific approach to identify new uses for existing drugs. About a third of orphan approvals by the FDA since the program began have […]

Repurposing acts to lower the need for early stage clinical trials. BBCR’s team of industry experts can help match treatments to rare genetic conditions and unsolved diseases, then work with a product developer on the best plan to market.

October 29th, 2019 | drug repurposing

People tend to believe that a repurposed therapy can never be truly novel or transformative. Nothing could be further from the truth. One attractive option of Drug Repurposing is to use a scientific approach to identify new uses for existing drugs. About a third of orphan approvals by the FDA since the program began have […]